IGHMBP2-Related Neuropathies: a Case Study for Ultra-Rare Gene Therapy Development

Time: 11:30 am
day: Preclinical Stream Day 1 AM

Details:

  • The most important things for developing a treatment for an ultra-rare disease
  • Having a clear molecular target, having good tools, and an engaged patient community

Speakers: